5 Pharmaceutical Stocks to Buy Now

by Portfolio Grader | October 18, 2013 12:00 pm

The grades of five Pharmaceutical stocks are better this week, according to the Portfolio Grader[1] database. Every one of these stocks has an “A” (“strong buy”) or “B” overall (“buy”) rating.

TherapeuticsMD, Inc. (AMEX:TXMD[2]) is making progress this week as its rating of C (“hold”) from last week increases to a B (“buy”) rating this week. TherapeuticsMD operates as a women’s healthcare product company in the United States. In Portfolio Grader’s specific subcategories of Earnings Revisions and Sales Growth, TXMD also gets A’s. For more information, get Portfolio Grader’s complete analysis of TXMD stock[3].

Johnson & Johnson (NYSE:JNJ[4]) is making headway this week, with the company’s rating improving to an A (“strong buy”) from a B (“buy”) last week. Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The stock’s dividend yield is 2.6%. For more information, get Portfolio Grader’s complete analysis of JNJ stock[5].

Bristol-Myers Squibb Company (NYSE:BMY[6]) improves from a C to a B rating this week. Bristol-Myers Squibb is a global company that develops, produces and sells pharmaceutical products. For more information, get Portfolio Grader’s complete analysis of BMY stock[7].

Watson Pharmaceuticals (NYSE:WPI[8]) boosts its rating from a B to an A this week. Watson develops, manufactures, markets, sells and distributes pharmaceutical products. For more information, get Portfolio Grader’s complete analysis of WPI stock[9].

This is a strong week for Repros Therapeutics (NASDAQ:RPRX[10]). The company’s rating climbs to A from the previous week’s B. Repros Therapeutics is a development stage biopharmaceutical company focusing on the development of oral small molecule drugs for major unmet medical needs. For more information, get Portfolio Grader’s complete analysis of RPRX stock[11].

Louis Navellier’s proprietary Portfolio Grader[12] stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here[13].

Endnotes:

  1. Portfolio Grader: https://navelliergrowth.investorplace.com/portfolio-grader/
  2. TXMD: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=TXMD
  3. For more information, get Portfolio Grader’s complete analysis of TXMD stock: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=TXMD
  4. JNJ: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=JNJ
  5. For more information, get Portfolio Grader’s complete analysis of JNJ stock: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=JNJ
  6. BMY: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=BMY
  7. For more information, get Portfolio Grader’s complete analysis of BMY stock: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=BMY
  8. WPI: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=WPI
  9. For more information, get Portfolio Grader’s complete analysis of WPI stock: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=WPI
  10. RPRX: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=RPRX
  11. For more information, get Portfolio Grader’s complete analysis of RPRX stock: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=RPRX
  12. Portfolio Grader: https://navelliergrowth.investorplace.com/portfolio-grader/
  13. here: https://navelliergrowth.investorplace.com/portfolio-grader/

Source URL: https://investorplace.com/2013/10/5-pharmaceutical-stocks-to-buy-now-txmd-jnj-bmy-2/

Copyright ©2024 InvestorPlace unless otherwise noted.